A detailed history of M&T Bank Corp transactions in Elanco Animal Health Inc stock. As of the latest transaction made, M&T Bank Corp holds 26,407 shares of ELAN stock, worth $318,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,407
Previous 26,407 -0.0%
Holding current value
$318,996
Previous $387,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$11.85 - $15.47 $17,348 - $22,648
1,464 Added 5.87%
26,407 $387,000
Q2 2024

Jul 31, 2024

BUY
$12.93 - $18.45 $33,876 - $48,339
2,620 Added 11.74%
24,943 $359,000
Q1 2024

May 07, 2024

SELL
$14.37 - $16.46 $488 - $559
-34 Reduced 0.15%
22,323 $363,000
Q4 2023

Feb 06, 2024

SELL
$8.6 - $14.94 $66,693 - $115,859
-7,755 Reduced 25.75%
22,357 $333,000
Q3 2023

Nov 02, 2023

BUY
$9.81 - $12.62 $10,388 - $13,364
1,059 Added 3.65%
30,112 $338,000
Q2 2023

Aug 09, 2023

BUY
$8.08 - $10.37 $30,970 - $39,748
3,833 Added 15.2%
29,053 $292,000
Q1 2023

May 11, 2023

BUY
$8.79 - $14.58 $65,010 - $107,833
7,396 Added 41.49%
25,220 $237,000
Q4 2022

Feb 13, 2023

BUY
$11.49 - $13.65 $24,714 - $29,361
2,151 Added 13.72%
17,824 $217,000
Q4 2022

Feb 13, 2023

SELL
$11.49 - $13.65 $2.51 Million - $2.99 Million
-218,883 Reduced 93.32%
15,673 $191,000
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $22,573 - $58,971
1,819 Added 0.78%
234,556 $2.89 Million
Q2 2022

Aug 05, 2022

SELL
$19.63 - $26.62 $733,985 - $995,348
-37,391 Reduced 13.84%
232,737 $4.57 Million
Q1 2022

May 09, 2022

BUY
$24.65 - $29.0 $677,751 - $797,355
27,495 Added 11.33%
270,128 $7.05 Million
Q4 2021

Feb 07, 2022

BUY
$27.74 - $34.09 $643,956 - $791,365
23,214 Added 10.58%
242,633 $6.89 Million
Q3 2021

Oct 28, 2021

BUY
$29.2 - $36.72 $545,748 - $686,296
18,690 Added 9.31%
219,419 $7 Million
Q2 2021

Aug 13, 2021

BUY
$28.76 - $35.98 $357,573 - $447,339
12,433 Added 6.6%
200,729 $6.96 Million
Q1 2021

May 06, 2021

BUY
$27.85 - $34.49 $531,071 - $657,689
19,069 Added 11.27%
188,296 $5.55 Million
Q4 2020

Feb 12, 2021

BUY
$27.53 - $33.79 $720,625 - $884,487
26,176 Added 18.3%
169,227 $5.19 Million
Q3 2020

Nov 06, 2020

BUY
$21.1 - $29.13 $557,841 - $770,138
26,438 Added 22.67%
143,051 $4 Million
Q2 2020

Jul 29, 2020

BUY
$18.94 - $24.93 $1.93 Million - $2.54 Million
101,930 Added 694.2%
116,613 $2.5 Million
Q1 2020

May 14, 2020

BUY
$16.68 - $32.25 $87,786 - $169,731
5,263 Added 55.87%
14,683 $329,000
Q4 2019

Feb 07, 2020

BUY
$25.29 - $29.45 $227 - $265
9 Added 0.1%
9,420 $277,000
Q3 2019

Nov 12, 2019

SELL
$25.62 - $34.96 $87,466 - $119,353
-3,414 Reduced 26.62%
9,411 $251,000
Q2 2019

Aug 12, 2019

BUY
$31.11 - $34.79 $398,985 - $446,181
12,825 New
12,825 $433,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.73B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.